CATUG Biotechnology provides novel CRDMO services with a particular focus on mRNA vaccines and therapeutics as well as
gene and cell therapy (GCT). Plasmid, mRNA, LNP, and analytical QC are our four fundamental technology platforms. Our strong
expertise and know-how aim to provide end-to-end solutions to our clients in the life cycle of mRNA therapeutics and GCT product
development. We customize unique services and creative solutions to fit each client’s needs and timeline.